InvestorsHub Logo
Followers 827
Posts 119503
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Tuesday, 10/04/2022 11:27:20 AM

Tuesday, October 04, 2022 11:27:20 AM

Post# of 245
EOLS launches Nuceiva* in UK:

https://www.businesswire.com/news/home/20221004005189/en

In the UK, Evolus is partnering with Wigmore Medical, known as a leading supplier of specialist products to aesthetics practitioners. Wigmore has been working in aesthetics for over 35 years, providing reliable pharmacy services and expertise, trusted by practitioners.

Evolus plans to introduce Nuceiva next in Germany and Austria in the first half of 2023, and is working closely with its partner, Novvia Pharm. Novvia was established in 2003 and is dedicated to providing leading brands to medical aesthetics practitioners in Germany and Austria. During 2023, the company expects to enter additional European countries, and, subject to regulatory approval, will also launch Nuceiva in Australia.

EOLS has previously acknowledged that European sales will be de minimis during 2022.

*The European brand name for Jeuveau.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EOLS News